# BDX — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-08-04. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 7.1 · Fundamentals 8 · Technicals 6.5 · Growth 8.5 · Risk 7

## Summary

BDX shows strong fundamentals with robust cash flow and key contracts, but near-term margin compression from recalls creates volatility. Technicals indicate upside potential within forecast bands amid improving momentum, though short interest and operational risks require caution.

## Price targets (6-month horizon)

- Bear: $150.25
- Base: $174.30
- Bull: $192.25

## News context

Recent news highlights BDX's Brazil semaglutide partnership with EMS as a key catalyst for growth in chronic disease care. However, the 19% undervaluation based on DCF is offset by negative net margins and product recall risks. The $176.30 target price from analysts aligns with the forecast band but requires confirmation of margin recovery post-earnings.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/bdx-ai-stock-forecast-69c1c106703e9272a09a4b26ca546a53
- AI-generated; model outputs can be wrong. Not financial advice.